Difference between revisions of "Zverova 2019 Neuropsychiatr Dis Treat"
(Created page with "{{Publication |title=Zvěřová M, Hroudová J, Fišar Z, Hansíková H, Kališová L, Kitzlerová E, Lambertová A, Raboch J (2019) Disturbances of mitochondrial parameters t...") |
|||
Line 14: | Line 14: | ||
|keywords=Affective disorder, Biomarker, Mitochondrial enzyme, Oxidative phosphorylation, Platelet | |keywords=Affective disorder, Biomarker, Mitochondrial enzyme, Oxidative phosphorylation, Platelet | ||
|editor=[[Plangger M]], | |editor=[[Plangger M]], | ||
|mipnetlab=CZ Prague Fisar Z, CZ Prague Zeman J | |||
}} | }} | ||
{{Labeling | {{Labeling |
Revision as of 15:39, 29 January 2019
Zvěřová M, Hroudová J, Fišar Z, Hansíková H, Kališová L, Kitzlerová E, Lambertová A, Raboch J (2019) Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder. Neuropsychiatr Dis Treat 15:233-40. |
Zverova M, Hroudova J, Fisar Z, Hansikova H, Kalisova L, Kitzlerova E, Lambertova A, Raboch J (2019) Neuropsychiatr Dis Treat
Abstract: Mitochondrial dysfunctions are implicated in the pathophysiology of mood disorders. We measured and examined the following selected mitochondrial parameters: citrate synthase (CS) activity, electron transport system (ETS) complex (complexes I, II, and IV) activities, and mitochondrial respiration in blood platelets.
The analyses were performed for 24 patients suffering from a depressive episode of bipolar affective disorder (BD), compared to 68 patients with MDD and 104 healthy controls. BD and unipolar depression were clinically evaluated using well-established diagnostic scales and questionnaires.
The CS, complex II, and complex IV activities were decreased in the depressive episode of BD patients; complex I and complex I/CS ratio were significantly increased compared to healthy controls. We observed significantly decreased complex II and CS activities in patients suffering from MDD compared to controls. Decreased respiration after complex I inhibition and increased residual respiration were found in depressive BD patients compared to controls. Physiological respiration and capacity of the ETS were decreased, and respiration after complex I inhibition was increased in MDD patients, compared to controls. Increased complex I activity can be a compensatory mechanism for decreased CS and complex II and IV activities.
We can conclude that complex I and its abnormal activity contribute to the defects in cellular energy metabolism during a depressive episode of BD. The observed parameters could be used in a panel of biomarkers that could selectively distinguish BD depression from MDD and can be easily examined from blood elements. • Keywords: Affective disorder, Biomarker, Mitochondrial enzyme, Oxidative phosphorylation, Platelet • Bioblast editor: Plangger M • O2k-Network Lab: CZ Prague Fisar Z, CZ Prague Zeman J
Labels: MiParea: Respiration, Patients
Pathology: Other
Organism: Human Tissue;cell: Platelet Preparation: Intact cells Enzyme: Complex I, Complex II;succinate dehydrogenase, Complex IV;cytochrome c oxidase
Coupling state: LEAK, ROUTINE, ET Pathway: ROX HRR: Oxygraph-2k
Labels, 2019-01